Evolus, Inc. (EOLS) Social Stream
EVOLUS INC (EOLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EVOLUS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 7 | $20 | $7 | $15.142 | $9.84 | 53.88% |
| 2022-01-27 | 6 | $20 | $7 | $15.142 | $9.84 | 53.88% |
| 2022-03-04 | 7 | $20 | $7 | $15.142 | $9.84 | 53.88% |
| 2022-04-21 | 7 | $20 | $7 | $15.428 | $9.84 | 56.79% |
| 2022-04-28 | 6 | $20 | $8 | $15.666 | $9.84 | 59.21% |
| 2022-05-11 | 6 | $20 | $8 | $16 | $9.84 | 62.6% |
| 2022-05-12 | 6 | $20 | $10 | $16.333 | $9.84 | 65.99% |
| 2022-10-13 | 7 | $20 | $10 | $16.571 | $9.84 | 68.4% |
| 2022-11-02 | 6 | $20 | $10 | $16.428 | $9.84 | 66.95% |
| 2022-11-09 | 7 | $20 | $10 | $16.428 | $9.84 | 66.95% |
| 2023-03-09 | 7 | $20 | $10 | $16.714 | $9.84 | 69.86% |
| 2023-05-09 | 8 | $20 | $10 | $16.75 | $9.84 | 70.22% |
| 2023-05-10 | 8 | $25 | $14 | $19.142 | $9.84 | 94.53% |
| 2023-05-26 | 7 | $25 | $16 | $19.714 | $9.84 | 100.35% |
| 2023-06-08 | 7 | $25 | $16 | $20.142 | $9.84 | 104.7% |
| 2023-07-23 | 6 | $25 | $16 | $20.5 | $9.84 | 108.33% |
| 2023-08-03 | 6 | $27 | $20 | $22.333 | $9.84 | 126.96% |
| 2023-11-08 | 5 | $27 | $20 | $23.5 | $9.84 | 138.82% |
The Trend in the Analyst Price Target
EOLS's average price target has moved up $8.75 over the prior 42 months.
Over the past 42 weeks, EOLS's average upside potential has been 124.66%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-19 | 7 | 20 | 10 | 16.714 | 10.52 | 58.88% |
| 2023-08-03 | 5 | 27 | 20 | 22.800 | 10.05 | 126.87% |
| 2023-08-03 | 5 | 27 | 20 | 22.333 | 10.05 | 122.22% |
| 2023-11-08 | 5 | 27 | 20 | 23.500 | 8.74 | 168.88% |
| 2023-11-08 | 5 | 27 | 20 | 22.800 | 8.74 | 160.87% |
EOLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
EOLS's average broker recommendation rating worsened by 0.06 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EOLS as an investment opportunity.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its average analyst price target is higher than 506.67% of that group.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1422.63% of that group.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1617.76% of that group.
- In terms of how EVOLUS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1736.48% of that group.
Stocks similar to EVOLUS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ACET, KZIA, and VYNE.
View All Top Stocks by Price Target
Is EOLS a Buy, Hold or Sell? See the POWR Ratings now!